You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Alcon Pharms Ltd Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ALCON PHARMS LTD, and what generic and branded alternatives to ALCON PHARMS LTD drugs are available?

ALCON PHARMS LTD has fourteen approved drugs.

Summary for Alcon Pharms Ltd

US Patents:	0
Tradenames:	13
Ingredients:	13
NDAs:	14

Drugs and US Patents for Alcon Pharms Ltd

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alcon Pharms Ltd	TOBRAMYCIN	tobramycin	SOLUTION/DROPS;OPHTHALMIC	063176-001	May 25, 1994		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Alcon Pharms Ltd	NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE	dexamethasone; neomycin sulfate; polymyxin b sulfate	SUSPENSION/DROPS;OPHTHALMIC	062721-001	Nov 17, 1986		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Alcon Pharms Ltd	BETAXON	levobetaxolol hydrochloride	SUSPENSION/DROPS;OPHTHALMIC	021114-001	Feb 23, 2000		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Alcon Pharms Ltd	GENTAMICIN SULFATE	gentamicin sulfate	SOLUTION/DROPS;OPHTHALMIC	062523-001	Nov 25, 1985		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Alcon Pharms Ltd	TRAVATAN	travoprost	SOLUTION/DROPS;OPHTHALMIC	021257-001	Mar 16, 2001		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
Alcon Pharms Ltd	TROPICAMIDE	tropicamide	SOLUTION/DROPS;OPHTHALMIC	089172-001	Dec 28, 1990		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Alcon Pharms Ltd	NEOMYCIN SULFATE-DEXAMETHASONE SODIUM PHOSPHATE	dexamethasone sodium phosphate; neomycin sulfate	SOLUTION/DROPS;OPHTHALMIC	062714-001	Jul 21, 1986		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Alcon Pharms Ltd

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alcon Pharms Ltd	BETAXON	levobetaxolol hydrochloride	SUSPENSION/DROPS;OPHTHALMIC	021114-001	Feb 23, 2000	4,911,920*PED	⤷ Subscribe
Alcon Pharms Ltd	TRAVATAN	travoprost	SOLUTION/DROPS;OPHTHALMIC	021257-001	Mar 16, 2001	6,011,062	⤷ Subscribe
Alcon Pharms Ltd	NAVSTEL	calcium chloride; dextrose; magnesium chloride; oxiglutatione; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate	SOLUTION;IRRIGATION	022193-001	Jul 24, 2008	7,084,130	⤷ Subscribe
Alcon Pharms Ltd	TRAVATAN	travoprost	SOLUTION/DROPS;OPHTHALMIC	021257-001	Mar 16, 2001	5,510,383	⤷ Subscribe
Alcon Pharms Ltd	NAVSTEL	calcium chloride; dextrose; magnesium chloride; oxiglutatione; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate	SOLUTION;IRRIGATION	022193-001	Jul 24, 2008	5,409,904	⤷ Subscribe
Alcon Pharms Ltd	BETAXON	levobetaxolol hydrochloride	SUSPENSION/DROPS;OPHTHALMIC	021114-001	Feb 23, 2000	5,540,918*PED	⤷ Subscribe
Alcon Pharms Ltd	TRAVATAN	travoprost	SOLUTION/DROPS;OPHTHALMIC	021257-001	Mar 16, 2001	6,235,781	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for ALCON PHARMS LTD drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Ophthalmic Solution	0.03%	➤ Subscribe	2004-12-23
➤ Subscribe	Ophthalmic Solution	0.00%	➤ Subscribe	2008-11-28

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.